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Rochester, Minnesota
Objectives. The objectives of this study were to 1) define the
incidence of syncope coming to medical attention among children
and adolescents, 2) determine the outcome of syncope in these
patients, and 3) determine changes over time in the evaluation
and charges for evaluating this problem.
Background. Syncope occurs commonly in children and adoles-
cents. However, the mid- and long-term outcome of children and
adolescents who experience syncope is unknown.
Methods. Utilizing the Rochester Epidemiology Project, we
determined the incidence, outcome and charges for medical
evaluation for patients seeking medical attention for syncope
during an early 5-year period (1950 to 1954) and a more recent
5-year period (1987 to 1991).
Results. The incidence of syncope coming to medical attention
was 71.9 and 125.8/100,000 population for the early and more
recent cohort, respectively. The incidence was higher for female
than for male patients. The incidence peaked in 15- to 19-year old
patients. Acute illness and noxious stimuli were associated with
24% and 23% of the episodes, respectively. Although long-term
survival was not different from that of the general population, one
child died suddenly, and another had hereditary prolonged QT
interval syndrome. These were two of only six patients who had
exertional syncope. Total charges for evaluation of syncope were
similar in the two time periods. However, charges for testing
procedures were greater for the more recent cohort.
Conclusions. In general, syncope in children and adolescents is
a benign event. Syncope occurring during exercise may identify
patients with a potentially fatal condition. Detailed evaluation
should be considered for patients who have syncope during exercise
or who have a family history of syncope, sudden death, myocardial
disease or arrhythmias. It may be prudent to obtain an electrocar-
diogram for all patients who seek medical attention for syncope.
(J Am Coll Cardiol 1997;29:1039–45)
©1997 by the American College of Cardiology
Syncope is relatively common in adolescence. Although syn-
cope can be a benign event, in some circumstances it can
herald a potentially lethal problem (1). In addition, syncope of
benign origin can lead to injury or death if loss of conscious-
ness occurs during a situation in which the patient is in
particular jeopardy. Thus, patients and physicians are anxious
to determine the cause of syncope, identify and treat poten-
tially lethal underlying causes of syncope and prevent future
syncopal episodes.
There is no population-based study of syncope in children
and adolescents on which guidelines for evaluation and man-
agement can be based. Most of the existing data come from
referral centers where the mix of patients may not reflect the
population at large. The purpose of this study was to 1) define
the incidence of syncope in children and adolescents that
comes to medical attention, 2) determine the outcome of
syncope in these patients, and 3) determine changes over time
in the evaluation of this problem and in the charges for
evaluating it.
Methods
Study setting. The population of Rochester, Minnesota is
served by a largely unified medical care system that has
accumulated comprehensive clinical records over an extended
period of time. Rochester (1990 population 70,745) lies 90
miles southeast of Minneapolis/St. Paul. In 1990, the popula-
tion was 96% white; 28% were .45 years old and 11% 65 years
or older. The population is largely middle class; ;82% of
adults have graduated from high school. With the exception of
a higher proportion of the working population employed in the
health care industry, the characteristics of the population of
Rochester are similar to those of U.S. whites.
Rochester Epidemiology Project. Epidemiologic research
in Rochester is possible because the city is relatively isolated
from other urban centers and nearly all medical care is
delivered to local residents by a small number of providers (2).
Most of this medical care is provided by the Mayo Clinic, a
major referral center with .1,000 full-time physicians repre-
senting every medical and surgical specialty and subspecialty.
Mayo Clinic, along with the Olmsted Medical Group and its
affiliated Olmsted Community Hospital, provide comprehen-
sive care for the region in every clinical discipline including
primary care.
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The epidemiologic potential of this situation is enhanced by
the fact that each provider uses a unit (or dossier) medical
record system whereby all data collected on an individual are
assembled in one place. The Mayo Clinic unit record, for
example, contains the details of every inpatient hospital stay at
its two large affiliated hospitals, every outpatient visit, every
physician visit to nursing homes or private homes, as well as
every laboratory result, pathology report (including autopsy
data) and piece of correspondence concerning each patient.
The unit records of each provider in the county have been
maintained and are available for use. These medical records
are easily retrievable because the Mayo Clinic has maintained,
since the early 1900s, extensive indexes based on clinical and
histologic diagnoses and surgical procedures. The Rochester
Epidemiology Project has developed a similar index for the
records of other providers of medical care to local residents.
The result is the linkage of medical records from essentially all
sources of medical care available to and utilized by the
Rochester population.
Identification of cases. The medical records of potential
cases were identified through the diagnostic indexes of the
Rochester Epidemiology Project. Potential cases were drawn
from persons falling under the diagnostic rubrics of syncope,
fainting, vasovagal attack, spells, consciousness disorders, va-
somotor instability, vasomotor attack, cardiogenic syncope and
heat syncope. These indexes do not capture the reason for
visits. Hence, patients who presented with syncope but were
found to have a more specific diagnosis may not have been
identified. Patients evaluated by all physician providers in the
community were included in this study. Once a potential case
was identified, the community medical records were reviewed
by a trained nurse abstracter to verify that 1) the syncopal
episode had occurred and was the initial syncopal episode for
which medical attention was sought, 2) the subject was a
resident of Rochester, Minnesota at the time of the episode, 3)
the subject was between 1 and 22 years of age at the time of the
episode, and 4) the syncopal episode occurred during calendar
years 1950 through 1954 (“1950s cohort”) or 1987 through
1991 (“1990s cohort”).
For the purposes of this study, syncope was defined as a
transient (,2 h) loss of consciousness (see Ref 7 for definitions
of specific types of syncope). It included witnessed as well as
unwitnessed events. It included instances in which cardiopul-
monary resuscitation was performed by a family member but
excluded instances in which cardiopulmonary resuscitation was
performed by medical or paramedical personnel. Also ex-
cluded were episodes of unconsciousness resulting from an
apparent seizure disorder. Although incontinence rarely can
be associated with syncope, we excluded cases in which the
patient was incontinent of urine or stool in an effort to exclude
all primary seizure disorders. Episodes preceded within 5 min
by major trauma also were excluded.
Residence was verified by using information from birth
certificates, city and county directories or earlier medical
records. Each subject’s residency status was determined on the
index date and 1 year before the index date to identify anyone
from the cohort who may have moved to Rochester to specif-
ically facilitate the diagnosis and treatment of conditions
associated with syncope.
Once a subject was identified and Rochester residence
confirmed, the community inpatient and outpatient medical
records were reviewed to determine the circumstances sur-
rounding the syncopal episode, the results of the initial diag-
nostic evaluation, as well as basic demographic information. In
addition, all subjects were passively followed up through their
medical records to determine their last known vital status,
occurrence of syncope and subsequent diagnostic studies and
outcome that might be related to syncope.
All persons not known to have died by June 1994 were
contacted by mail questionnaire. Questionnaire elements elic-
ited information about vital status, recurrence of syncopal
episodes, date of last episode, injuries associated with syncopal
episodes and additional evaluation of syncope performed
outside of Olmsted County. Medical questionnaires were
sent to 196 patients known not to have died. Completed
questionnaires were received from 111 patients. Telephone
contact was made and questionnaire information was ob-
tained for an additional 49 patients. Current vital status was
determined for 183 of the 196 patients; 13 patients were lost
to follow-up.
Once collected, the abstracted data were entered into a
computer and verified by trained data entry personnel. The
data then were edited with a variety of on-line range and
consistency checks. Quality control and adherence to the
protocol approved by the Mayo Clinic Institutional Review
Board were ensured by the close supervision of the principal
investigator and coinvestigators.
Data analysis. Incidence rates were calculated by assuming
that the population of Rochester was at risk. Denominators for
incidence rates were based on decennial census data, with
linear interpolation for intracensal estimates (3). Poisson
regression was used to test for differences in incidence rates
due to gender, period and age group. Differences in the
distribution of associated signs and symptoms, related activities
and physician diagnosis were tested with the Wilcoxon rank-
sum test for ordinal variables and the chi-square statistic for
categoric variables. When expected frequencies were ,5 for
any cell in contingency tables, the Fisher exact test was used. A
standardized mortality ratio was estimated by comparing the
observed number of deaths among cohort members to an
expected number based on State of Minnesota decennial life
tables (4).
Total charges between periods were compared with a
two-sample Wilcoxon rank-sum test. To assess the relative
charges for medical evaluation, typical commercial non-
Medicare insurance fees for 1994 were used. Three sets of
charges were examined: 1) the charge for the initial medical
encounter, 2) the charges for testing, and 3) the charges for
subsequent medical follow-up or consultation. All analyses
were carried out with SAS Institutes statistical software.
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Results
A search of the Rochester Epidemiology Diagnostic Index
yielded 447 potential cases with the diagnostic rubrics outlined
earlier. Of these, 194 (43%) fulfilled all inclusion criteria.
Reasons for exclusion included non-Rochester resident (n 5
101), outside of age criteria (n 5 11), outside of examination
date (n 5 7), no documented true syncope (n 5 116),
associated incontinence (n 5 2) and prior medical attention for
a syncopal episode (n 5 16).
The 1950s cohort comprised 43 patients, 40 white and 3 of
unknown ethnicity; 31 were female and 12 were male. The
1990s cohort comprised 151 patients, 98 female and 53 male;
131 were white, 3 were southeast Asian and 17 were of
unknown ethnicity. The median age of the female patients was
18 and 16 years for the 1950s and the 1990s cohort, respectively
(p 5 0.65). The median age of the male patients was 10.5 and
13 years for the 1950s and the 1990s cohort, respectively (p 5
0.51).
Syncopal episodes occurring before the index episode for
which the patient sought medical attention were noted for 25
(58%) of the 43 patients in the 1950s cohort and for 47 (31%)
of the 151 patients in the 1990s cohort.
Incidence. The incidence of syncopal episodes coming to
medical attention per 100,000 population was 71.9 and 125.8
for the 1950s and the 1990s group, respectively. The age-
adjusted incidence rates were higher for female (89.8 and
166.3) than for male (47.8 and 92.9) patients for the 1950s and
the 1990s cohort, respectively. For both male and female
patients, the rate peaked in the 15- to 19-year old group, but
the peak for female patients was dramatically greater than that
for male patients (Fig. 1). The gender, period and age group
main effect and gender by age group interaction effect are all
highly significant (p 5 0.04, 0.003, 0.0001 and 0.002, respec-
tively). The period by age group interaction is marginally
significant (p 5 0.073).
Signs and symptoms. Signs and symptoms associated with
the index syncopal episode are displayed in Table 1. Injury
resulting from the syncopal episode, or light-headedness, nau-
sea/vomiting, dizziness or visual symptoms associated with the
episode, occurred in 18%, 16%, 15%, 14% and 12% of
patients, respectively. There were essentially no differences in
the proportion of signs and symptoms between the two co-
horts, with the exception of light-headedness, which occurred
more frequently in the 1990s cohort (20% vs. 5%, p 5 0.02).
Activities or events associated with the episode or patient
location during the episode are listed in Table 2. The presence
of an acute illness or the use of prescription drugs was
associated with 24% and 20%, respectively, of episodes. Nox-
ious stimuli or psychologic/emotional stimuli were associated
with 23% and 12%, respectively, of episodes. Syncope oc-
curred during exercise in 6 (3%) of 194 patients.
Most of the index episodes were evaluated initially in the
emergency room or the outpatient clinic. However, in the
1950s cohort, 23% were evaluated by house call. Visits for
further medical evaluation after the initial evaluation for the
index syncopal episode were performed for 56% of the 1950s
cohort and for 47% of the 1990s cohort.
Diagnostic categories. The majority of patients were
thought by the attending physician to have had either a simple
faint or vasodepressor or vasovagal syncope (Table 3).
A variety of diagnostic tests were performed (Table 4). The
profile of tests performed differed for the two cohorts. For
example only 1 (2%) of 43 of patients from the 1950s cohort
but 35 (23%) of 151 patients from the 1990s cohort had
electrocardiograms (ECGs) performed. Glucose and electro-
lyte measurements were performed much more frequently in
the later than in the earlier cohort. Fewer diagnostic studies
Figure 1. Age-specific incidence of syncope in children and adoles-
cents by year. Vertical bars are 95% confidence intervals.
Table 1. Signs, Symptoms and Events Associated With Incident*
Syncopal Events: Residents of Rochester, Minnesota Aged 1 to 22








Value†No. % No. % No. %
Tonic-clonic movements 3 7 12 8 15 8 1.00
Seizure 0 0 4 3 4 2 0.58
Injury from syncope 6 14 29 19 35 18 0.51
Trauma preceding syncope 1 2 12 8 13 7 0.30
Minor 1 2 10 7 11 6 0.46
Moderate 0 0 2 1 2 1 1.00
Head 0 0 8 5 8 4 0.20
Other 1 2 5 3 6 3 1.00
Nausea/vomiting 5 12 24 16 29 15 0.63
Vertigo 1 2 3 2 4 2 1.00
Anticipation of syncope 3 7 14 9 17 9 0.77
Feeling hot 5 12 10 7 15 8 0.33
Headache 0 0 6 4 6 3 0.34
Dizziness 5 12 23 15 28 14 0.63
Light-headedness 2 5 30 20 32 16 0.02
Pallor 1 2 1 1 2 1 0.40
Sweaty 3 7 6 4 9 5 0.42
Cold 1 2 5 3 6 3 1.00
Weak/shaky 2 5 4 3 6 3 0.62
Visual symptoms 3 7 21 14 24 12 0.30
*Incident event 5 first syncopal episode brought to medical attention. †p
value for test of difference between time periods.
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were performed for the 1950s cohort (71 tests in 43 patients)
than for the 1990s cohort (479 tests in 151 patients).
Thirty-five patients had ECGs. Among these, the corrected
QT intervals ranged from 0.35 to 0.44. Although no patients
had a prolonged QT interval, one adolescent who died sud-
denly (described later) had not had an ECG performed.
Another adolescent did not have an ECG performed when
evaluated for his index episode of syncope, but after a subse-
quent episode he was found to have prolonged QT interval
syndrome.
Outcome. Mortality. Three patients died; all were from the
1950s cohort. In two of these patients, the death had no
apparent relation to previous syncopal episodes. One of the
two patients committed suicide at age 41 years, and the second
died of liver failure secondary to viral hepatitis at age 27 years.
Mortality was no different from that of an age-matched
population. In a comparable age- and gender-matched popu-
lation, the expected number of deaths was 3.0.
The third patient died suddenly and unexpectedly at age 13
years. This patient stood up to recite in class, complained of
feeling faint, collapsed and died. Four months before his
death, he had had syncope (the index episode) while running.
It was reported that he was unconscious for 20 min. Seven
months before his death he had also had syncope while
running. No ECG was ever performed.
Recurrence. Syncopal episodes occurring after the index
episode were noted for 3 (7%) of 43 patients in the 1950s
cohort and for 14 (9%) of 151 patients in the 1990s cohort.
Associated medical conditions. As part of the follow-up
questionnaire the presence of specific medical conditions was
ascertained (Table 5). Migraine headaches were reported in 28
(18%) of 152 of the patients. Subsequent development of
diabetes mellitus was more common in the 1950s than in the
1990s cohort. This difference probably reflects the longer
follow-up period for the 1950s cohort.
Charges for medical evaluation. The total charge for the
initial medical encounter, testing and subsequent medical
follow-up or consultation was not significantly different for the
1950s cohort (mean $577.77, median $326) and 1990s cohort
(mean $641.48, median $303.00). However, the charge per
patient for tests performed was significantly (p , 0.05) higher
for patients evaluated in the 1990s ($289/patient) than for
those evaluated in the 1950s ($77/patient). The charges for
follow-up evaluation and consultation were higher for the
Table 2. Activities and Locations Associated With Incident* Syncopal Events: Residents of Rochester,








Value†No. % No. % No. %
Cough 1 2 0 0 1 1 0.22
Crying 0 0 5 3 5 3 0.59
Urination 1 2 3 2 4 2 1.00
Defecation 0 0 2 1 2 1 1.00
Menses 5 12 7 5 12 6 0.16
In church 2 5 3 2 5 3 0.31
In shower/bath 0 0 11 7 11 6 0.13
After a noxious stimulus 13 30 32 21 45 23 0.22
After psychologic/emotional stimulus 5 12 18 12 23 12 1.00
During exercise 1 2 5 3 6 3 1.00
,5 min after exercise 1 2 1 1 2 1 0.40
Acute illness 9 21 38 25 47 24 0.69
Nonprescription drugs/alcohol 0 0 16 11 16 8 0.025
Prescription drug 2 5 37 25 39 20 0.003
*Incident event 5 first syncopal episode brought to medical attention. †p value for test of difference between time
periods.
Table 3. Attending Physicians’ Diagnosis After Initial Evaluation of
Incident* Syncopal Event: Residents of Rochester, Minnesota: Aged










Value†No. % No. % No. %
Simple faint 21 49 44 29 65 34 0.016
Vasodepressor/vasovagal 6 14 61 40 67 35 0.001
Hysteria/psychogenic 1 2 3 2 4 2 1.00
Breathholding 0 0 6 4 6 3 0.34
Concurrent infectious
disease
1 2 3 2 4 2 0.89
Possible epilepsy 6 14 3 2 9 5 0.001
Syncope 3 7 6 4 9 5 0.41
Orthostatic 1 2 2 1 3 2 0.64
Hyperventilation 1 2 1 1 2 1 0.34
Hypoglycemia 0 0 3 2 3 2 0.35
Unknown 6 14 6 4 12 6 0.017
Other‡ 4 9 22 15 28 13 0.37
*Incident event 5 first syncopal episode brought to medical attention. †p
value for test of difference between time periods. ‡Includes, among other
diagnoses, chest pain, sunburn, exhaustion, dysmenorrhea, medication-related
condition, vertigo, trauma, dehydration, stress, alcohol-related condition.
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1950s cohort ($557/patient) than for the 1990s cohort ($287/
patient). This difference was due to a higher rate of emergency
room and repeat outpatient evaluation of patients in the 1950s
than in the 1990s cohort.
Discussion
Syncope in adults. The epidemiologic features of syncope
were reported for 2,336 adult men and 2,873 adult women as
part of the Framingham study (5). These subjects ranged in age
from 30 to 62 years. During the course of 13 biennial exami-
nations, 71 of the men and 101 of the women reported at least
one syncopal episode during their lifetime. Isolated syncope
(i.e., transient loss of consciousness in the absence of prior or
concurrent neurologic, coronary or other cardiovascular dis-
ease stigmata) occurred in 79% of the men and 88% of the
women with syncope. During 26 years of follow-up, isolated
syncope was unassociated with excess stroke, myocardial in-
farction or mortality from other causes. Kapoor et al. (6,7)
prospectively studied 204 adult patients with syncope. A car-
diovascular cause of the syncope was identified in 53 patients
and a noncardiovascular cause in 54; in 97 patients the cause
remained unknown. After 12 months of follow-up the overall
mortality rate was 14 6 2.5%. The mortality rate was 30 6
6.7% for patients with a cardiovascular cause of syncope and
6.7 6 2.8% for patients with syncope of unknown cause.
Syncope in children. There have been few studies of
syncope in children and, to our knowledge, no population-
based studies. Pratt and Fleisher (8) reported the evaluation
and outcome of 77 children and adolescents who were evalu-
ated in an emergency room for syncope. These patients ranged
in age from 22 months to 21 years (mean 12.7 years). On
review of the records, 37 (48%) of the 77 patients were deemed
not to have had syncope. This is similar to our finding that 36%
of patients coded as having syncope did not have syncope. In the
study of Pratt and Fleisher, 50% of the patients had vasovagal
syncope, 20% had orthostatic syncope, 7.5% had atypical
seizures, 5% had migraine headaches and 5% had minor head
trauma. The occurrence of migraine headaches in their study is
Table 4. Laboratory and Clinical Tests Performed During Initial Evaluation* of Incident† Syncopal











No. % No. No. % No.
CBC 13 30 13 63 42 76 0.22
Glucose 4 9 4 48 32 67 0.003
Electrolytes 0 0 0 48 32 67 0.000001
Urinalysis 15 35 15 31 21 40 0.07
ECG 1 2 1 35 23 37 0.001
24-h ECG 0 0 0 10 7 10 0.12
Echocardiogram 0 0 0 4 3 4 0.58
Tilt table 0 0 0 1 1 1 1.00
Electrophysiologic study 0 0 0 1 1 1 1.00
Exercise test 0 0 0 1 1 1 1.00
Electroencephalogram 6 14 6 27 18 28 0.65
CT scan 0 0 0 22 15 26 0.005
Skull radiograph 8 19 8 15 10 17 0.18
Other 24 56 24 79 52 104 0.73
Total tests 71 479
*Initial evaluation included all tests performed within the 1st 6 months after the initial medical visit for syncope.
†Incident event 5 first syncopal episode brought to medical attention. ‡p value for test of difference in proportion of
patients tested between time periods. CBC 5 complete blood count; CT 5 computed tomography; ECG 5
electrocardiogram.
Table 5. Medical Conditions Reported During Follow-Up:
Residents of Rochester, Minnesota Aged 1 to 22 Years With






(n 5 121)† Total
p
Value‡No. % No. % No. %
Diabetes 2 6 0 0 2 1 0.04
Seizures 0 0 7 6 7 5 0.35
Arrhythmias 3 10 4 3 7 5 0.15
Prolonged QT
interval syndrome
0 0 1 1 1 1 1.00
Pulmonary hypertension 1 3 0 0 1 1 0.20
Migraine headaches 5 16 23 19 28 18 0.80
Mitral valve prolapse 1 3 3 2 4 3 1.00
*Incident event 5 first syncopal episode brought to medical attention. †n 5
patients with complete follow-up information. ‡p value for test of difference
between time periods.
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interesting in light of our finding that 18% of our patients
reported migraine headaches. As in the present study only a
small number of patients had an abnormal blood count or
serum glucose level. Pratt and Fleisher concluded that the
routine evaluation of the child with syncope should include a
history and physical examination with measurement of heart
rate and blood pressure in supine and standing positions, an
ECG and serum glucose and hematocrit measurements.
Gordon et al. (9) reported on 73 children and adolescents
evaluated at the Cleveland Clinic for syncope between 1981
and 1986. The patients ranged in age from 2.5 to 20 years
(mean 13). Specific problems were identified in seven patients.
These problems included myocardial disease, atrioventricular
node reentrant tachycardia, muscular dystrophy, sick sinus
syndrome and febrile seizures. These 73 patients had a total of
443 diagnostic test and consultations (6/patient). A relatively
large number (n 5 29) of the patients were admitted to the
hospital. The charges for the patients admitted to the hospital
were $4,882/patient, whereas the average charge for evaluation
for the entire group of patients was $2,973/patient. In the
current study the average charge/patient was $627.36 ($577.77/
patient in the 1950s cohort and $641.48/patient in the 1990s
cohort). The discrepancy of diagnoses encountered and in
charges between our study and that of Gordon et al. is most
likely due to the fact that their patients reflected a referred
group of patients whereas ours represented a local population-
based group of patients.
Study limitations. We found an incidence of syncope that
ranged from 71.9 to 125.8/100,000 population. This represents
a lower boundary estimate of syncope in the general popula-
tion of children and adolescents because only syncopal epi-
sodes that came to medical attention were included in the
study. From a practitioner’s standpoint, of course, these are
the only episodes with which one must deal. Interpretation of
the observed changes in incidence is also problematic. It is not
possible to determine whether these changes were due to a real
change in incidence, changes in care seeking, changes in care
seeking behavior or changes in coding practices.
It is possible that we underestimated the occurrence of
significant and potentially lethal underlying or associated med-
ical conditions. If a patient presented for evaluation of syncope
but was found to have a specific disease entity (e.g., cardiomy-
opathy), the dismissal code may have been specific for the
disease entity and not reflective of the presenting symptom of
syncope. This patient may not have been identified by our
study method. Depending on the directions and magnitude of
these potential biases, the overall outcome for syncope may be
better or worse than that reported here.
Although clinicians frequently assign a diagnostic label to
patients with syncope, it is difficult to distinguish, for example,
among several types of syncope such as vasovagal syncope,
simple faint and orthostatic syncope. One may find variations
from study to study or for different time periods within a study
in the distributions of the descriptive categories for syncope.
Consequently, any shifts in the distributions of the descriptive
categories in this study should be interpreted with caution.
Cost of evaluation. To our knowledge, our study is the only
population-based study and is the first to compare the charges
for evaluation of syncope in children and adolescents in two
different eras. Not surprisingly, the charge for medical tests/
patient was significantly higher in the more recent cohort. It is
difficult to know if this resulted from the availability of more
sophisticated testing procedures, the presence of increased
medical-legal pressures or the desire to make a more specific
diagnosis. It was surprising to find that the total charge for
evaluation was similar for the early and later cohorts. The
increased charges for tests performed for the more recent
cohort were offset by the greater number of evaluations
performed on inpatients in the 1950s cohort.
Appropriate medical and cost-effective evaluation of a
condition such as syncope is inherently related to the outcome
of the condition. A condition associated with low or no risk of
death and minimal morbidity may not require extensive and
expensive medical evaluation. If a subset of patients has a
different outcome from the rest of the cohort, it is useful to
identify that subset so that appropriate medical evaluation can
be targeted toward it rather than toward the entire cohort. In
the two studies cited earlier there was no mortality associated
with syncope in children and adolescents. In the present study
with long follow-up, the risk of death was similar to that
expected in the general population. However, there was one
instance of sudden unexpected death in a young child that
potentially could have been prevented. In addition, a second
patient ultimately was identified to have a potentially lethal
condition (long QT interval syndrome). Thus, although syn-
cope in children and adolescents is a benign event for the vast
majority of patients, it can be associated with sudden death in
a very small number of patients. It is important to develop
cost-effective algorithms to identify these rare persons.
Exercise and syncope. It is known that sudden death in
children and adolescents can be associated with, among other
conditions, hypertrophic cardiomyopathy, anomalous origin of
the left coronary artery from the right sinus of Valsalva,
myocarditis, long QT interval syndrome, cystic medial necrosis
and Wolff-Parkinson-White syndrome. There also is some
suggestion that syncope that occurs during exertion may por-
tend a worse outcome than syncope that is unassociated with
exercise. Indeed, in the present study only six patients had
syncope in association with exercise. Of these, one patient
ultimately died and a second had long QT interval syndrome.
Conclusions and recommendations. On the basis of the
current and previous studies we propose the following strategy.
It is very important to obtain a detailed personal and family
history for all patients who seek medical attention for syncope.
One should seek information regarding a family history of
sudden unexpected death, as well as the patient’s personal and
family history of myocardial disease, syncope, arrhythmias and
other conditions associated with sudden death. All patients
should have a physical examination. Patients with exertional
syncope or a positive personal or family history should have a
more detailed evaluation. The details of that evaluation should
be dictated by the specific case. Some might argue that all
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children and adolescents who faint should have an ECG
although this recommendation is not supported by the results
of this study. Additional testing will have a low yield and not be
cost-effective for patients with negative findings in the personal
and family history, a normal physical examination and nonex-
ertional syncope. This approach should be evaluated in a
clinical trial.
We thank Margaret E. (Peg) Farrell, RN for diligent review of the medical
records and Christine Boos, BS for assistance in analytic programming.
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